Properties (75)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
A method for improving efficiency.
|
| gptkbp:applicationNumber |
US_12345678
|
| gptkbp:applicationType |
non-provisional
|
| gptkbp:assignee |
gptkb:Acme_Corporation
|
| gptkbp:assigneeCountry |
gptkb:USA
|
| gptkbp:citedBy |
gptkb:US_4,567,890_B2
|
| gptkbp:claims |
20
|
| gptkbp:description |
This patent describes a novel compound.
|
| gptkbp:examinationType |
substantive examination
|
| gptkbp:expirationDate |
1984-03-10
|
| gptkbp:fieldOfInvention |
Pharmaceuticals
|
| gptkbp:filingDate |
1962-01-15
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 3,123,432 B2
|
| gptkbp:internationalClassification |
A61K 31/00
|
| gptkbp:inventor |
gptkb:John_Doe
|
| gptkbp:inventorCountry |
gptkb:USA
|
| gptkbp:inventorResidence |
gptkb:California
|
| gptkbp:issueDate |
1964-03-10
|
| gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
| gptkbp:legalEvent |
maintenance fee paid
|
| gptkbp:patentAbstract |
none.
recognized for innovation. developed over a period of 5 years. developed through collaboration. funded by private investors. has a positive societal impact. introduces a new chemical compound. licensed to various pharmaceutical companies. part of an ongoing innovation cycle. presented at industry conferences. received industry awards. related to drug formulation. significant in the pharmaceutical industry. assigned_to_Acme_Corporation. commercialized_by_Acme_Corporation. enforced_by_Acme_Corporation. |
| gptkbp:patentCitation |
gptkb:US_2,987,654_B2
available in public databases. based on extensive laboratory research. competes with similar patents. ethical considerations in its use. expected to remain relevant. faces challenges from generics. generates significant revenue. holds a large market share. reflects trends in pharmaceutical development. supported by research grants. targeted at the healthcare market. widely used in treatments. |
| gptkbp:patentClassification |
A61K
A61K 9/00 |
| gptkbp:patentExpiration |
20 years from filing date.
|
| gptkbp:patentFamily |
US_3,123,432_B2,_US_3,456,789_B2
|
| gptkbp:patentFilingDate |
published in scientific journals.
|
| gptkbp:patentInventor |
prosecuted_by_John_Smith.
|
| gptkbp:patentLitigation |
none
no known litigation. |
| gptkbp:patentMaintenanceFee |
requires maintenance fees.
estimated at millions. sustainable in the long term. |
| gptkbp:patentNumber |
3,123,432
|
| gptkbp:patentOffice |
gptkb:USPTO
|
| gptkbp:patentStatus |
granted
has a lasting legacy in the field. |
| gptkbp:patentType |
utility
A utility patent for a new invention. filed under 35 U.S.C. 111. granted on March 10, 1964. has a global reach. FDA_approved. regulated_by_the_FDA. |
| gptkbp:priorityDate |
1961-01-15
|
| gptkbp:relatedTo |
gptkb:US_3,456,789_B2
|
| gptkbp:status |
active
|